Pharmacovigilance deep dive: risk minimisation measures
European Pharmaceutical Review
SEPTEMBER 2, 2022
She has worked with regulatory agencies and pharmaceutical companies for over 10 years. She also has been conducting fundamental research as an academic in several universities, with her last academic position held at Harvard Medical School. Before that she has been an independent scientific advisor. About the author.
Let's personalize your content